The same group has reported that brain-derived soluble factors upregulate the expression of CCR4 in both cutaneous and brain-metastasizing melanoma cells and enhance the migration of the latter, but not that of the cutaneous variants (Klein et al., 2012). This evidence concerns the gene CCR4 and melanoma.